BENDHEIM JACK (President and CEO) sold 20.8% of their position (7.04K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $296.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/2/2025ACC: 0001104659-25-117716
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-7.04K
Net shares
Net seller
$296.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
7.04K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−3.52K
Price / share
$42.54
Trade value
$149.74K
% of position
10.4%
11/28/2025
33.84K→30.32K
Class A Common Stock
Indirect
Shares
−3.52K
Price / share
$41.66
Trade value
$146.64K
% of position
11.6%
12/1/2025
30.32K→26.80K
Total
Net shares
−7.04K
Net value
-$296.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 11/28/2025 | S · Sale | −3.52K | $42.54 | $149.74K | 10.4% | 33.84K | 30.32K |
| Class A Common Stock Indirect | 12/1/2025 | S · Sale | −3.52K | $41.66 | $146.64K | 11.6% | 30.32K | 26.80K |
| Total | −7.04K | -$296.38K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported